Based on Japan’s excellent medical technology, GN Corporation will disseminate new solutions to the world that span the fields of cell culture, tissue engineering, regenerative medicine, medical devices, medical devices, metadata, databases, artificial intelligence, preventive medicine, and health foods.
We will hold academic exchange meetings to promote exchange between different fields such as clinical medicine, materials, and science, and contribute to the development of regenerative medicine.
| Japan-In dia BioSciences (P) Ltd | B6, 13, Zakariah Colony III St, Choolaimedu Chennai 600 094, TN, INDIA Tel: +91-44 -23720805, 23720806, 94440-82048 Fax: +91-44 – 24732186 |
|---|---|
| Nichi-in Center for Regenerative Medic ine, Japan-India Regenerative Medicine | III F, LICET, Loyola Campus, Nungambakkam, Chennai 600094, TN, India Tel: +91-44-28174743, +91-44-64549484 Fax: +91-44-24732186 |
| Company name | GN Corporation Co Ltd |
|---|---|
| Location | 〒400-0866 3-8 Wakamatsu, Kofu Yamanashi, JAPAN TEL. 055-235-7527 FAX. 055-235-7569 Email: info@gncorporation.com |
| Established. | August 2002 |
| Bank | Yamanashi Central Bank, Rakuten Bank |
| Patent No. 5863089 | Gel film for the treatment of corneal endothelitis cell defects |
|---|---|
| Patent No. 6373241 | How cells are stored |
| Patent No. 6714247 | Urethral stenosis treatment agent and urethral stenosis treatment method |
| Patent No. 6757578 | Method for enhancing the function of immune and blood cells by TGP-containing storage solution and microgravity load |
Neu REFIX beta glucans improving Multiple Sclerosis patients’ gut microbiome awarded as the best poster
Nichi BRITE Beta glucans yileding clinically encouraging outcome in a trial was presented in the webinar that commemorated World Parkinsons Day held on the 10th April 2023
Neurology Live, a clinical neurologists focused media portal has published GN Corporation’s presentation at the MDA on the Clinical trial results of Neu REFIX in Duchenne Muscular Dystrophy
